Publication Details

Pubmed29973690
Title: FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation.
Year: 2018
DOI: https://doi.org/10.1038/s41388-018-0372-3
First Author: Cui
Experimental setup: affinity chromatography technology (Biogrid)
imaging technique (Biogrid)
Throughput: Low Throughput (Biogrid)

Interactions

1 interaction
InteractorPartnerSourcesLink
CDCP1_HUMANFXL14_HUMANBioGRIDdetails